Abstract #1003503: A Phase 2, Interventional, Randomized, Double-Blind, Placebo-Controlled Pilot Study of Glucagon Ready-To-Use in Subjects Who Experience Hyperinsulinemic Hypoglycemia After Bariatric Surgery

Helen M. Lawler; Mary Elizabeth Patti; Valentina Conoscenti; M. Khaled Junaidi; Nicole C. Close; David J. Sequeira; Anh Nguyen

doi:10.1016/j.eprac.2021.04.575

Abstract #1003503: A Phase 2, Interventional, Randomized, Double-Blind, Placebo-Controlled Pilot Study of Glucagon Ready-To-Use in Subjects Who Experience Hyperinsulinemic Hypoglycemia After Bariatric Surgery

Endocrine Practice ◽

10.1016/j.eprac.2021.04.575 ◽

2021 ◽

Vol 27 (6) ◽

pp. S49

Author(s):

Helen M. Lawler ◽

Mary Elizabeth Patti ◽

Valentina Conoscenti ◽

M. Khaled Junaidi ◽

Nicole C. Close ◽

...

Keyword(s):

Bariatric Surgery ◽

Pilot Study ◽

Hyperinsulinemic Hypoglycemia ◽

Phase 2 ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Resmetirom (MGL-3196) for the treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial

Yearbook of Paediatric Endocrinology ◽

10.1530/ey.17.14.9 ◽

2020 ◽

Author(s):

Harrison SA ◽

Bashir MR ◽

Guy CD ◽

Zhou R ◽

Moylan CA ◽

...

Keyword(s):

Phase 2 ◽

Double Blind ◽

Double Blind Placebo ◽

Alcoholic Steatohepatitis ◽

Phase 2 Trial

Download Full-text

NGM282 for treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial

Yearbook of Paediatric Endocrinology ◽

10.1530/ey.15.15.7 ◽

2018 ◽

Author(s):

Harrison SA ◽

Rinella ME ◽

Abdelmalek MF ◽

Trotter JF ◽

Paredes AH ◽

...

Keyword(s):

Phase 2 ◽

Double Blind ◽

Double Blind Placebo ◽

Alcoholic Steatohepatitis ◽

Phase 2 Trial

Download Full-text

A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate Reduction in Inflammation in Patients With Advanced Chronic Renal Disease Utilizing Antibody Mediated IL-6 Inhibition

Case Medical Research ◽

10.31525/ct1-nct03926117 ◽

2019 ◽

Author(s):

Keyword(s):

Renal Disease ◽

Chronic Renal Disease ◽

Controlled Trial ◽

Phase 2 ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Randomized, Double-Blind, Placebo-Controlled Pilot Study on the Safety and Effectiveness of LUCEMYRA During an Opioid Taper in Treatment of Withdrawal

Case Medical Research ◽

10.31525/ct1-nct04070157 ◽

2019 ◽

Author(s):

Keyword(s):

Pilot Study ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Faculty Opinions recommendation of A double-blind, placebo-controlled pilot study of quetiapine for depressed adolescents with bipolar disorder.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1168312.630474 ◽

2009 ◽

Author(s):

Robert Findling

Keyword(s):

Bipolar Disorder ◽

Pilot Study ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Faculty Opinions recommendation of A randomized, double-blind, placebo-controlled pilot study to assess the ability of rifaximin to prevent recurrent diarrhoea in patients with Clostridium difficile infection.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.13349966.14726746 ◽

2011 ◽

Author(s):

Shafiqul A Sarker

Keyword(s):

Pilot Study ◽

Clostridium Difficile ◽

Clostridium Difficile Infection ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Faculty Opinions recommendation of A randomized, double-blind, placebo-controlled pilot study to assess the ability of rifaximin to prevent recurrent diarrhoea in patients with Clostridium difficile infection.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.13349966.14721054 ◽

2011 ◽

Author(s):

Reto Nüesch

Keyword(s):

Pilot Study ◽

Clostridium Difficile ◽

Clostridium Difficile Infection ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Faculty Opinions recommendation of Intravenous aflibercept for treatment of recurrent symptomatic malignant ascites in patients with advanced ovarian cancer: a phase 2, randomised, double-blind, placebo-controlled study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.13931968.15387072 ◽

2012 ◽

Author(s):

Michael Fisch

Keyword(s):

Ovarian Cancer ◽

Advanced Ovarian Cancer ◽

Malignant Ascites ◽

Controlled Study ◽

Phase 2 ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Faculty Opinions recommendation of Elagolix treatment for endometriosis-associated pain: results from a phase 2, randomized, double-blind, placebo-controlled study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718047281.793481249 ◽

2013 ◽

Author(s):

Jim Tsaltas

Keyword(s):

Controlled Study ◽

Phase 2 ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Faculty Opinions recommendation of P2X3 receptor antagonist (AF-219) in refractory chronic cough: a randomised, double-blind, placebo-controlled phase 2 study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.725255169.793503497 ◽

2015 ◽

Author(s):

Brendan J Canning

Keyword(s):

Receptor Antagonist ◽

Chronic Cough ◽

Phase 2 ◽

P2x3 Receptor ◽

Double Blind ◽

Double Blind Placebo ◽

Phase 2 Study

Download Full-text